Tumour shrinkage measured with first treatment evaluation under VEGF-targeted therapy as prognostic marker

Tumour shrinkage measured with first treatment evaluation under VEGF-targeted therapy as prognostic marker in metastatic renal cell carcinoma (mRCC).10/30/2013

Source: Kidney Cancer Association - October 30, 2013 Category: Cancer & Oncology Source Type: news